Shin Nippon Biomedical Laboratories, Ltd.
Simbolis: 2395.T
JPX
1392
JPYRinkos kaina šiandien
10.3343
P/E santykis
-0.0844
PEG koeficientas
57.95B
MRK kapitalizacija
- 0.04%
DIV pajamingumas
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 10533.1 | 6997 | 7286.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -423.6 | 368.1 | 55.8 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 4760.4 | 3501.6 | 2954.1 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 7329.4 | 4359.4 | 4071.4 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1276.7 | 1276.5 | 468.1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 23899.6 | 16134.5 | 14780 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18879.3 | 13155.8 | 12898 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 1438.8 | 0.3 | 0.8 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 260.7 | 212 | 213 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1699.4 | 212.3 | 213.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 12404 | 8645 | 8522 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 325.8 | 1129.6 | 521.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 34.2 | 35.4 | 37 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 33342.6 | 23178.2 | 22192.4 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 419.8 | 64.6 | 95 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 8923.2 | 2942.7 | 3486.8 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 603.7 | 743.1 | 683.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9837.5 | 6195.6 | 9199.2 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -1064 | -68.2 | -642.4 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3009.8 | 2685.1 | 2317.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 9871.5 | 6215.6 | 9217.8 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 357 | 385.8 | 529.3 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 30883.2 | 19589.5 | 21133.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 2620.8 | 105.7 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9679.1 | 9679.1 | 9679.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13766.2 | 10196.3 | 3854.5 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 460.2 | -2620.8 | -105.7 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2306.4 | -314.3 | 2200.9 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 26211.8 | 19561.1 | 15734.5 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 147.2 | 162 | 104.3 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 26359 | 19723.1 | 15838.8 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 11980.4 | 7080.1 | 8286.9 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 18760.7 | 9138.3 | 12686.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 8227.6 | 2509.4 | 5455.3 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -951.7 | 4338.5 | 3628.7 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 25090.9 | 17748.5 | 15110.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 12044.2 | 8061.2 | 7556.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 13046.7 | 9687.3 | 7554.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 7801.4 | 5491.7 | 5024.9 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 19845.7 | 13552.9 | 12581 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 57.4 | 8.3 | 3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5245.2 | 4195.6 | 2529.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1708.9 | 1016.2 | 497.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 6060.1 | 7127.6 | 3661.9 |
Dažnai užduodami klausimai
Kas yra Shin Nippon Biomedical Laboratories, Ltd. (2395.T) bendras turtas?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) bendras turtas yra 57242205000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.522.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 85.787.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.206.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.150.
Kas yra Shin Nippon Biomedical Laboratories, Ltd. (2395.T) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 6060057000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 18760662000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 7801426000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.